NEWS RELEASE for February 10, 2005 at 8:00AM Eastern Time

Contacts: Investor Relations
Palomar Medical Technologies Inc
781-993-2411
ir@palomarmedical.com


PALOMAR MEDICAL REPORTS RECORD REVENUES AND PROFITABILITY
FOR FOURTH QUARTER AND FISCAL YEAR 2004
Fourth Quarter Revenues Increase 63 Percent; Net Income Increases 417 Percent

        BURLINGTON, MA (February 10, 2005) … Palomar Medical Technologies Inc (Nasdaq:PMTI), a leading researcher and developer of light-based systems for cosmetic treatments, today announced financial results for the fourth quarter and year ended December 31, 2004. The Company’s fourth quarter total revenues increased by 63 percent, product revenues increased by 51 percent, and gross profit from product sales improved by 73 percent as compared to the same quarter in 2003. The Company realized a significant increase in income from operations of $3.2 million, or 297 percent, and a net income improvement of $4.3 million, or 417 percent, as compared to the fourth quarter of 2003. The Company also strengthened its balance sheet since the end of last year, including increasing its cash position from $10.6 million to $25.2 million.

        Revenues for the quarter ended December 31, 2004, were $16.4 million, up from $10.1 million in the fourth quarter of 2003. Gross profit from product sales increased to $9.6 million (69 percent of product revenues), up from $5.5 million (60 percent of product revenues) in the year-earlier quarter. The Company reported income from operations of $4.2 million for the fourth quarter of this year, as compared to $1.1 million for the fourth quarter of last year. The Company reported net income of $5.4 million, or $0.29 per diluted share, which includes a benefit from income taxes of $1.1 million from the reduction of tax reserves, for the fourth quarter of this year, versus net income of $1.0 million, or $0.06 per diluted share, for the fourth quarter of last year.

        Revenues for the year ended December 31, 2004, were $54.4 million, up from $34.8 million for the same period in 2003. Gross profit from product sales increased to $30.3 million (66 percent of revenues), up from $18.3 million (58 percent of revenues) in the year-earlier period. The Company reported net income of $10.6 million, or $0.60 per diluted share for the year ended December 31, 2004, versus net income of $3.4 million, or $0.21 per diluted share for the same period in 2003.

        During fiscal year 2004, the Company announced the following events:

        — The Company and The Gillette Company (NYSE: G) completed the initial phase of their agreement and moved into the next phase. In conjunction with entering this next phase, the parties amended the agreement to provide for additional development funding to further technical innovations. The original agreement provided for $7 million in development funding from Gillette. Under the amendment, Gillette will provide $2.1 million in additional development funding over a nine month extension of the development phase, for a total of $9.1 million, which is planned to be completed by August 31, 2006.

        — The Company and Johnson & Johnson Consumer Companies, Inc, a Johnson & Johnson company, signed an agreement to develop, clinically test and potentially commercialize home-use, light-based devices for (i) reducing or reshaping body fat including cellulite; (ii) reducing appearance of skin aging; and (iii) reducing or preventing acne.

— more —


The following information was filed by Palomar Medical Technologies Inc (PMTI) on Thursday, February 10, 2005 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Palomar Medical Technologies Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Palomar Medical Technologies Inc.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account